[HTML][HTML] Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective

S Halawa, SS Pullamsetti, CRM Bangham… - Nature Reviews …, 2022 - nature.com
The lungs are the primary target of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) infection, with severe hypoxia being the cause of death in the most critical cases …

An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages

H Motamedi, MM Ari, S Dashtbin, M Fathollahi… - International …, 2021 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of
the rapidly spreading pandemic COVID-19 in the world. As an effective therapeutic strategy …

[HTML][HTML] To stress or not to stress: Brain-behavior-immune interaction may weaken or promote the immune response to SARS-CoV-2

EMJ Peters, M Schedlowski, C Watzl, U Gimsa - Neurobiology of stress, 2021 - Elsevier
The COVID-19 pandemic continues to strongly affect people with health disadvantages,
creating a heavy burden on medical systems and societies worldwide. Research is growing …

[HTML][HTML] Carotenoids: Therapeutic strategy in the battle against viral emerging diseases, COVID-19: An overview

A Khalil, D Tazeddinova, K Aljoumaa… - … Nutrition and Food …, 2021 - ncbi.nlm.nih.gov
Carotenoids, a group of phytochemicals, are naturally found in the Plant kingdom,
particularly in fruits, vegetables, and algae. There are more than 600 types of carotenoids …

[HTML][HTML] SARS-CoV-2 spike protein induces endothelial inflammation via ACE2 independently of viral replication

AC Montezano, LL Camargo, S Mary, KB Neves… - Scientific Reports, 2023 - nature.com
Abstract COVID-19, caused by SARS-CoV-2, is a respiratory disease associated with
inflammation and endotheliitis. Mechanisms underling inflammatory processes are unclear …

[HTML][HTML] Rapamycin: drug repurposing in SARS-CoV-2 infection

J Patocka, K Kuca, P Oleksak, E Nepovimova, M Valis… - Pharmaceuticals, 2021 - mdpi.com
Since December 2019, SARS-CoV-2 (COVID-19) has been a worldwide pandemic with
enormous consequences for human health and the world economy. Remdesivir is the only …

Diabetes and COVID-19: The potential role of mTOR

B Pinchera, R Scotto, AR Buonomo, E Zappulo… - Diabetes Research and …, 2022 - Elsevier
Diabetes is the most frequent comorbidity among patients with COVID-19. COVID-19
patients with diabetes have a more severe prognosis than patients without diabetes …

Targeted therapy in Coronavirus disease 2019 (COVID-19): Implication from cell and gene therapy to immunotherapy and vaccine

M Shirzad, M Nourigorji, A Sajedi, M Ranjbar… - International …, 2022 - Elsevier
Severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) is a highly pathogenic and
transmissible virus. Infection caused by SARS-CoV-2 known as Coronavirus disease 2019 …

[HTML][HTML] SARS-CoV-2: Pathogenesis, molecular targets and experimental models

G Kanimozhi, B Pradhapsingh… - Frontiers in …, 2021 - frontiersin.org
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a recent pandemic
outbreak threatening human beings worldwide. This novel coronavirus disease-19 (COVID …

[HTML][HTML] Intricate relationship between SARS-CoV-2–induced shedding and cytokine storm generation: A signaling inflammatory pathway augmenting COVID-19

MB Moftah, A Eswayah - Health Sciences Review, 2022 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), through its ability to
induce cytokine release syndrome, can set up a generalized inflammatory response …